NEW YORK (GenomeWeb News) – Germany's Bernhard Nocht Institute for Tropical Medicine and ADT Altona Diagnostic Technologies recently announced a collaboration to develop and market tests for tropical diseases.
The public-private partnership is budgeted for €9.6 million ($12.6 million) over the next four years, with €4.6 million in funding provided by the government of the City of Hamburg in Germany. The money is from the European Fund of Regional Development, an instrument of the European Union.
A "core element" of the partnership will be a specimen bank dedicated to several tropical and rare diseases, though the institute and Altona did not elaborate. In addition to being used by the partners for test development, the reference specimens will be accessible to third parties and customers, they said.
Both the institute and Altona are based in Hamburg. The institute focuses on serologic test development and has expertise in the epidemiology of tropical diseases. It also has a collection of tropical and orphan pathogens and specimens from infected patients.
Altona develops nucleic acid-based tests with a focus on infectious diseases.